What Are Wall Street Analysts' Target Price for Raymond James Stock?
Raymond James Financial (RJF), with a $29.5B market cap, has lagged the S&P 500 over the past year and in 2026, though its shares are up 3.4% over 52 weeks and down 5.6% YTD. For FY ending Sept. 2026, analysts expect diluted EPS of $11.83 (+11% YoY). Among 15 analysts, consensus is “Moderate Buy” (5 Strong Buy, 10 Hold). Morgan Stanley raised its target to $172; mean target is $173.92 and Street-high $198.
How this was made
The 30-second read
Why it matters
For traders, the actionable signal is sentiment calibration (Moderate Buy) plus incremental estimate/target lift tied to investment banking revenue and net interest income expectations; the dividend provides a modest near-term support narrative.
Market read
This is a sentiment/target update with a small fundamental rationale (IB revenue and NII expectations) and a dividend catalyst that previously coincided with a modest stock reaction.
What to watch
Earnings surprise history is mixed (3/4 beats, 1 miss), so investors may discount targets if macro conditions or deal activity weaken.
Background
The article summarizes Wall Street’s target-price landscape for Raymond James and references a recent dividend approval and a prior Morgan Stanley target increase.
Ticker impact
Raymond James (RJF) received a dividend approval and an analyst price-target raise citing higher investment banking revenue and net interest income expectations.
Near-term bias to mild upside or support on any pullbacks, but limited catalyst strength since the piece is primarily analyst-target aggregation.
The article highlights a dividend approval (with a +1.1% post-announcement move) and a Morgan Stanley target increase from $171 to $172, while broader guidance is not newly changed beyond estimate tweaks.
Market effects
Supports the view that diversified broker-dealers may benefit from improving investment banking and interest-rate-linked net interest income assumptions.
Primarily US financials sentiment; no specific Canada/UK catalyst identified beyond the company’s footprint.
Limited global spillover; story is analyst-driven for a single US financial name.
Counterpoint
Analyst target changes may already be priced in; dividend and estimate tweaks do not guarantee execution in investment banking or NII.
Key entities
- companyRaymond James Financial, Inc.
Diversified financial services firm; subject of analyst target-price and dividend updates in the article.
- analyst_firmMorgan Stanley
Raised its RJF price target to $172 from $171 and increased 2026/2027 EPS estimates.
